Infinitt Healthcare is a leading Korean healthcare IT solutions specializing in medical imaging and enterprise imaging platforms. It is the number one provider of PACS system in Korea.
Five major investment highlights include strong export growth, solid growth in sales and operating profits, number one player in PACS system in Korea, strong balance sheet, and attractive valuations.
The company has a strong balance sheet. Net cash was 150 billion won at the end of 1Q 2025, representing 95% of its market cap.
Investment Highlights
The following are the five major investment highlights of Infinitt Healthcare (071200 KS) :
Strong export growth - The company is experiencing a strong export growth. Exports as a percentage of total sales increased from 55.8% in 2023 to 60.7% in 2024 and 66.67% in 1Q 2025. Its exports increased by 24.8% YoY in 2024.
Solid growth in sales and operating profits - The company's sales and operating profits increased at CAGR of 9.1% and 24.3%, respectively from 2021 to 2024.
Number one player for PACS system in Korea - The company is the number one player for PACS systems in Korea with nearly 70% market share. The company serves more than 1,500 medical institutions for its PACS systems. It has a loyal and stable customer base for its PACS and other medical imaging platforms in Korea.
Strong balance sheet - The company has a strong balance sheet. Net cash was 150 billion won at the end of 1Q 2025, representing 95% of its market cap. Debt ratio was 27% at the end of 1Q 2025.
Attractive Valuations - The company is trading at attractive valuations. It is trading at EV/EBITDA of 0.5x based on LTM EBITDA and 0.9x P/B multiple based on equity of 179 billion won at the end of 1Q 2025.
Infinitt Digital Pathology Solution (Source: Company data)
Keep reading with a 7-day free trial
Subscribe to Douglas Research Insights to keep reading this post and get 7 days of free access to the full post archives.